- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
市场最近连续上涨中，短期小心回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有99家主力机构披露2024-12-31报告期持股数据，持仓量总计11.33亿股，占流通A股66.05%
- 波段诊断：
-
技术面诊股
诊断结果：8.4技术面打败了90%的股票
技术面评分前10的股票
近期的平均成本为6.97元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为6.97元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.97","date":1752395793,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2025.07.14","stock":"1.75","trade":"1.60","ind":"0.27"},{"date":"2025.07.11","stock":"6.51","trade":"0.93","ind":"0.01"},{"date":"2025.07.10","stock":"0.62","trade":"1.32","ind":"0.48"},{"date":"2025.07.09","stock":"0.00","trade":"-0.64","ind":"-0.13"},{"date":"2025.07.08","stock":"0.31","trade":"0.54","ind":"0.70"},{"date":"2025.07.07","stock":"-0.93","trade":"-0.55","ind":"0.02"},{"date":"2025.07.04","stock":"-0.31","trade":"0.41","ind":"0.32"},{"date":"2025.07.03","stock":"1.25","trade":"2.52","ind":"0.18"},{"date":"2025.07.02","stock":"0.00","trade":"-1.00","ind":"-0.09"},{"date":"2025.07.01","stock":"3.40","trade":"3.49","ind":"0.39"},{"date":"2025.06.30","stock":"0.49","trade":"0.95","ind":"0.59"},{"date":"2025.06.27","stock":"0.00","trade":"0.71","ind":"-0.70"},{"date":"2025.06.26","stock":"-0.65","trade":"-1.17","ind":"-0.22"},{"date":"2025.06.25","stock":"0.16","trade":"-0.56","ind":"1.03"},{"date":"2025.06.24","stock":"1.15","trade":"1.39","ind":"1.15"},{"date":"2025.06.23","stock":"0.49","trade":"1.63","ind":"0.65"},{"date":"2025.06.20","stock":"-0.16","trade":"0.13","ind":"-0.07"},{"date":"2025.06.19","stock":"-3.18","trade":"-2.75","ind":"-0.79"},{"date":"2025.06.18","stock":"-0.94","trade":"-1.39","ind":"0.04"},{"date":"2025.06.17","stock":"4.61","trade":"-1.56","ind":"-0.04"},{"date":"2025.06.16","stock":"-0.82","trade":"0.52","ind":"0.35"}]
华北制药,上证指数,化学制药指数
压力支撑
该股压力位为6.91元，支撑位为6.71元。
[{"text":"\u538b\u529b\u4f4d","value":"6.91","date":1752422400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.71","date":1752422400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.7资金面打败了55%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月14日 20:30
| 机构今日流向(万元) | 510.20 | 机构5日流向(万元) | -2293.52 |
| 机构10日流向(万元) | -3126.64 | 机构20日流向(万元) | -15519.47 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量增加2378.10万股，其中基金净减仓9家，主力净增仓35家，请投资者中长期谨慎为宜。
截止2024-12-31，共99家主力机构（基金88家，一般法人9家，券商1家，券商集合理财1家），持仓量总计113331.92万股，占流通A股66.05%
其中，基金持仓与2024-06-30相比：
增仓：14家 ，增持 767.83万股
减仓：23家 ，减持 290.31万股
新出现在主力名单中：53家 ，持有2665.66万股
从主力名单中消失：18家 ，原持有1636.14万股
其中，基金持仓与2024-06-30相比：
增仓：14家 ，增持 767.83万股
减仓：23家 ，减持 290.31万股
新出现在主力名单中：53家 ，持有2665.66万股
从主力名单中消失：18家 ，原持有1636.14万股
消息面诊股
诊断结果：8.3消息面打败了98%的股票
今日有利好新闻的公司
近期利好消息较多且有重大利好，消息面发出积极信号。
更多>>个股资讯
- 午后A股、港股医药相关板块回暖，同标的规模最大生物
2025-07-14 - 华北制药：7月11日获融资买入2853.37万元，
2025-07-12 - 中报行情拉开帷幕，这些板块业绩预喜
2025-07-11 - 华北制药：7月10日获融资买入458.95万元，占
2025-07-11 - 华北制药：预计2025年半年度净利润同比增加72%
2025-07-10 - 华北制药：7月9日获融资买入440.06万元，占当
2025-07-10 - 华北制药：7月8日获融资买入1088.95万元，占
2025-07-09 - 华北制药：7月7日获融资买入873.91万元
2025-07-08 - 价格前线|7月7日维生素E异动提示
2025-07-07 - 华北制药：7月4日获融资买入836.54万元
2025-07-05
消息列表
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-12 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-05-22 |
| 一般消息 | 高管变动 | 因连续任职已满六年 | 2025-05-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-24 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-17 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 2条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：8.2行业面打败了98%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，明显跑赢大盘。
[{"date":"2025.07.14","price":"0.27","value":"1.60"},{"date":"2025.07.11","price":"0.01","value":"0.93"},{"date":"2025.07.10","price":"0.48","value":"1.32"},{"date":"2025.07.09","price":"-0.13","value":"-0.64"},{"date":"2025.07.08","price":"0.70","value":"0.54"},{"date":"2025.07.07","price":"0.02","value":"-0.55"},{"date":"2025.07.04","price":"0.32","value":"0.41"},{"date":"2025.07.03","price":"0.18","value":"2.52"},{"date":"2025.07.02","price":"-0.09","value":"-1.00"},{"date":"2025.07.01","price":"0.39","value":"3.49"},{"date":"2025.06.30","price":"0.59","value":"0.95"},{"date":"2025.06.27","price":"-0.70","value":"0.71"},{"date":"2025.06.26","price":"-0.22","value":"-1.17"},{"date":"2025.06.25","price":"1.03","value":"-0.56"},{"date":"2025.06.24","price":"1.15","value":"1.39"},{"date":"2025.06.23","price":"0.65","value":"1.63"},{"date":"2025.06.20","price":"-0.07","value":"0.13"},{"date":"2025.06.19","price":"-0.79","value":"-2.75"},{"date":"2025.06.18","price":"0.04","value":"-1.39"},{"date":"2025.06.17","price":"-0.04","value":"-1.56"},{"date":"2025.06.16","price":"0.35","value":"0.52"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海翔药业 | 276.83% | 2.83% | 6.4分 |
| 2 | 前沿生物 | 84.42% | 34.82% | 6.8分 |
| 3 | 联环药业 | 67.14% | 38.60% | 6.6分 |
| 4 | 广生堂 | 62.24% | 11.84% | 6.0分 |
| 5 | 微芯生物 | 49.10% | 3.60% | 7.0分 |
| 6 | 昂利康 | 45.93% | 1.64% | 6.3分 |
| 8 | 莱美药业 | 26.25% | 24.29% | 6.5分 |
| 10 | 悦康药业 | 21.98% | -2.75% | 6.7分 |
| 12 | 美诺华 | 19.94% | -7.39% | 5.7分 |
| 14 | 诚意药业 | 18.60% | 9.10% | 7.0分 |
| 16 | 多瑞医药 | 17.93% | 11.63% | 6.3分 |
| 18 | 小方制药 | 15.31% | 10.13% | 6.2分 |
| 20 | 花园生物 | 14.82% | 4.03% | 5.5分 |
| 22 | 华特达因 | 14.18% | 1.04% | 5.0分 |
| 24 | 京新药业 | 12.85% | 4.04% | 6.3分 |
| 26 | 博瑞医药 | 12.54% | 15.41% | 6.6分 |
| 28 | 泰恩康 | 10.75% | 5.20% | 6.4分 |
| 30 | 圣诺生物 | 9.87% | 6.45% | 6.3分 |
| 32 | 西点药业 | 9.73% | 3.51% | 6.2分 |
| 34 | 翰宇药业 | 8.63% | 0.05% | 6.8分 |
| 36 | 华纳药厂 | 8.51% | 10.36% | 6.8分 |
| 38 | 舒泰神 | 8.15% | -4.40% | 6.0分 |
| 40 | 天宇股份 | 7.52% | 4.56% | 6.9分 |
| 42 | 亚太药业 | 7.49% | 3.74% | 6.6分 |
| 44 | 键凯科技 | 6.93% | 8.37% | 6.8分 |
| 46 | 宏源药业 | 6.57% | -0.84% | 5.0分 |
| 48 | 恒瑞医药 | 6.42% | 8.66% | 7.2分 |
| 50 | 华仁药业 | 6.19% | 2.39% | 6.3分 |
| 52 | 民生健康 | 5.91% | -0.34% | 4.7分 |
| 54 | 金城医药 | 5.68% | 2.29% | 5.6分 |
| 56 | 福元医药 | 5.56% | -2.64% | 6.7分 |
| 58 | 首药控股 | 5.47% | 10.05% | 6.4分 |
| 60 | 艾力斯 | 5.31% | 7.32% | 7.1分 |
| 62 | 东亚药业 | 5.09% | 2.54% | 5.7分 |
| 64 | 中关村 | 4.53% | 1.65% | 6.2分 |
| 66 | 兴齐眼药 | 4.04% | 5.25% | 6.3分 |
| 68 | 司太立 | 3.63% | 3.83% | 6.8分 |
| 70 | 天新药业 | 3.44% | 0.68% | 6.6分 |
| 72 | 金石亚药 | 3.23% | 5.90% | 6.1分 |
| 74 | 华海药业 | 3.14% | -4.02% | 5.8分 |
| 76 | 福安药业 | 2.98% | 2.75% | 6.3分 |
| 78 | 本立科技 | 2.40% | -0.68% | 5.9分 |
| 80 | 华润双鹤 | 2.35% | 1.79% | 6.1分 |
| 82 | 健康元 | 2.27% | 2.27% | 6.3分 |
| 84 | 海森药业 | 2.17% | -2.21% | 5.6分 |
| 86 | 亿帆医药 | 1.87% | 6.84% | 6.5分 |
| 88 | 人福医药 | 1.76% | 1.13% | 6.3分 |
| 90 | 哈药股份 | 1.58% | 1.58% | 6.8分 |
| 92 | 仟源医药 | 1.52% | 10.33% | 6.1分 |
| 94 | 九典制药 | 1.06% | 1.69% | 5.8分 |
| 96 | 迪哲医药 | 1.01% | 0.29% | 7.1分 |
| 98 | 向日葵 | 0.87% | 3.26% | 5.7分 |
| 100 | 海思科 | 0.86% | 6.88% | 6.8分 |
| 102 | 海普瑞 | 0.66% | 3.22% | 6.8分 |
| 104 | 新和成 | 0.60% | -0.73% | 6.2分 |
| 106 | 海欣股份 | 0.28% | 3.49% | 6.0分 |
| 108 | 诺泰生物 | 0.23% | 2.88% | 6.6分 |
| 110 | 北大医药 | -0.61% | 1.09% | 5.8分 |
| 112 | 川宁生物 | -1.06% | 0.75% | 5.4分 |
| 114 | 哈三联 | -1.35% | 3.22% | 5.4分 |
| 116 | 海南海药 | -1.58% | 5.05% | 5.3分 |
| 118 | 科源制药 | -1.84% | 2.93% | 5.9分 |
| 120 | 健友股份 | -3.61% | 0.00% | 5.2分 |
| 122 | 苑东生物 | -3.88% | 2.84% | 6.0分 |
| 124 | 常山药业 | -4.45% | 7.19% | 6.3分 |
| 126 | *ST苏吴 | -5.35% | -5.74% | 5.0分 |
| 128 | 一品红 | -6.65% | 1.45% | 6.3分 |
| 130 | 科伦药业 | -8.70% | -4.73% | 4.3分 |
| 132 | 新诺威 | -11.32% | 0.18% | 5.5分 |
| 134 | 力生制药 | -12.11% | 2.12% | 6.2分 |
| 136 | 海辰药业 | -13.13% | -5.59% | 5.1分 |
| 138 | 信立泰 | -15.67% | -1.99% | 5.6分 |
| 140 | - | -23.69% | 0.00% | 分 |
| 142 | 宣泰医药 | - | 5.22% | 5.5分 |
| 144 | 辰欣药业 | - | 0.45% | 4.6分 |
| 146 | 神奇制药 | - | 1.79% | 5.4分 |
| 148 | 双鹭药业 | - | 3.40% | 5.4分 |
| 150 | 广济药业 | - | 1.97% | 6.5分 |
| 152 | 新华制药 | - | 4.36% | 6.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 79/227 ， 117/227。
[{"date":"2025-03-31","value":"1.06","vol":"-0.17"},{"date":"2024-12-31","value":"2.37","vol":"19.44"},{"date":"2024-09-30","value":"1.92","vol":"4.58"},{"date":"2024-06-30","value":"1.35","vol":"3.53"},{"date":"2024-03-31","value":"0.34","vol":"2.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.06 | 2.37 | 1.92 | 1.35 | 0.34 |
| 行业(%) | -0.17 | 19.44 | 4.58 | 3.53 | 2.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"29.44","vol":"49.23"},{"date":"2024-12-31","value":"31.97","vol":"51.10"},{"date":"2024-09-30","value":"30.26","vol":"50.51"},{"date":"2024-06-30","value":"29.90","vol":"50.84"},{"date":"2024-03-31","value":"30.59","vol":"50.75"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.44 | 31.97 | 30.26 | 29.90 | 30.59 |
| 行业(%) | 49.23 | 51.10 | 50.51 | 50.84 | 50.75 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 62/227 ， 8/227。
[{"date":"2025-03-31","value":"0.65","vol":"-0.86"},{"date":"2024-12-31","value":"-2.48","vol":"17.58"},{"date":"2024-09-30","value":"-5.20","vol":"45.26"},{"date":"2024-06-30","value":"-0.04","vol":"705.46"},{"date":"2024-03-31","value":"-3.86","vol":"744.46"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
0.65 | -2.48 | -5.20 | -0.04 | -3.86 |
| 行业(%) | -0.86 | 17.58 | 45.26 | 705.46 | 744.46 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"216.72","vol":"-21.71"},{"date":"2024-12-31","value":"2496.80","vol":"-40.60"},{"date":"2024-09-30","value":"266.29","vol":"-0.63"},{"date":"2024-06-30","value":"171.17","vol":"8.83"},{"date":"2024-03-31","value":"234.89","vol":"18.72"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
216.72 | 2496.80 | 266.29 | 171.17 | 234.89 |
| 行业(%) | -21.71 | -40.60 | -0.63 | 8.83 | 18.72 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 51/227 ， 42/227。
[{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.47","vol":"0.43"},{"date":"2024-09-30","value":"0.35","vol":"0.33"},{"date":"2024-06-30","value":"0.24","vol":"0.23"},{"date":"2024-03-31","value":"0.12","vol":"0.12"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.47 | 0.35 | 0.24 | 0.12 |
| 行业(次) | 0.10 | 0.43 | 0.33 | 0.23 | 0.12 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.74","vol":"0.67"},{"date":"2024-12-31","value":"2.62","vol":"3.23"},{"date":"2024-09-30","value":"2.08","vol":"2.17"},{"date":"2024-06-30","value":"1.41","vol":"1.51"},{"date":"2024-03-31","value":"0.68","vol":"0.74"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.74 | 2.62 | 2.08 | 1.41 | 0.68 |
| 行业(次) | 0.67 | 3.23 | 2.17 | 1.51 | 0.74 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"6.34","vol":"-28.86"},{"date":"2024-12-31","value":"7.41","vol":"-368.97"},{"date":"2024-09-30","value":"7.52","vol":"-9.88"},{"date":"2024-06-30","value":"11.82","vol":"-252.28"},{"date":"2024-03-31","value":"22.17","vol":"-3.76"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.34 | 7.41 | 7.52 | 11.82 | 22.17 |
| 行业 | -28.86 | -368.97 | -9.88 | -252.28 | -3.76 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.90","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.77","vol":"2.19"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.90 | - | 0.77 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.19 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 91/227 ， 56/227。
[{"date":"2025-03-31","value":"0.73","vol":"3.59"},{"date":"2024-12-31","value":"0.75","vol":"3.32"},{"date":"2024-09-30","value":"0.78","vol":"3.67"},{"date":"2024-06-30","value":"0.77","vol":"3.60"},{"date":"2024-03-31","value":"0.81","vol":"3.71"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.73 | 0.75 | 0.78 | 0.77 | 0.81 |
| 行业 | 3.59 | 3.32 | 3.67 | 3.60 | 3.71 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.50","vol":"2.81"},{"date":"2024-12-31","value":"0.49","vol":"2.62"},{"date":"2024-09-30","value":"0.52","vol":"2.92"},{"date":"2024-06-30","value":"0.50","vol":"2.89"},{"date":"2024-03-31","value":"0.50","vol":"3.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.50 | 0.49 | 0.52 | 0.50 | 0.50 |
| 行业 | 2.81 | 2.62 | 2.92 | 2.89 | 3.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/227 ， 7/227。
[{"date":"2025-03-31","value":"69.30","vol":"33.96"},{"date":"2024-12-31","value":"68.91","vol":"34.28"},{"date":"2024-09-30","value":"69.57","vol":"32.89"},{"date":"2024-06-30","value":"69.87","vol":"33.06"},{"date":"2024-03-31","value":"69.80","vol":"32.53"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
69.30 | 68.91 | 69.57 | 69.87 | 69.80 |
| 行业(%) | 33.96 | 34.28 | 32.89 | 33.06 | 32.53 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.80","vol":"1.46"},{"date":"2024-12-31","value":"2.75","vol":"0.84"},{"date":"2024-09-30","value":"2.82","vol":"0.72"},{"date":"2024-06-30","value":"2.85","vol":"0.70"},{"date":"2024-03-31","value":"2.73","vol":"0.69"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.80 | 2.75 | 2.82 | 2.85 | 2.73 |
| 行业(%) | 1.46 | 0.84 | 0.72 | 0.70 | 0.69 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"0.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-6.89","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.05","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.27","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.95","blueLineValue":"0.11","type":"YC"}]